Advertisement: TTP Killer 50
26 October, 2016 - 11:53 By News Desk


Healx Tim Guilliams

The drug repurposing business raised £1.5m in October 2016 from Hermann Hauser’s Amadeus Capital Partners and big names in biotech including David Brown, one of the inventors of Viagra. 

Healx uses advanced data analytics, including machine learning and computational biology techniques, alongside scientific literature analysis to identify novel drug applications for rare diseases that afflict some 350 million people worldwide.

Its model engages directly with patient advocacy groups, allowing them to lead the way in personalised healthcare for rare diseases.


Newsletter Subscription

Stay informed of the latest news and features